logo

Stock Screener

Forex Screener

Crypto Screener

DHAI

DIH Holdings US, Inc. Class A Common Stock (DHAI)

$

0.19

+0.02 (10.53%)


Key metrics

Financial statements

Free cash flow per share

Free cash flow per share

0.0555

Market cap

Market cap

9 Million

Price to sales ratio

Price to sales ratio

0.1346

Debt to equity

Debt to equity

-0.3968

Current ratio

Current ratio

0.5105

Income quality

Income quality

-0.2835

Average inventory

Average inventory

8.8 Million

ROE

ROE

0.2555



Technology

Technology

Technology – consumer electronics

Largecap

Largecap

With a market cap of 121,78 bil stock is ranked 1

Low risk

Low risk

ISS score of this stock is ranked 1


Company description

Profile

DIH Holding US, Inc. operates as a robotics and virtual reality technology provider in the rehabilitation and human performance industry, based in Norwell, Massachusetts. The operating income ratio is -0.04 indicating the company's operational profitability margin. Additionally, the income before tax ratio is -0.11 reflecting the pre-tax margin of the business. Despite this, the company reported a net loss of -$8,443,000.00 indicating challenges in its operations. The gross profit ratio is 0.46 which reflects the efficiency of the company's production and sales operations. Furthermore, the cost of revenue for the company is $34,702,000.00 showcasing its production and operational expenses. As the company navigates these financial metrics, it continues to focus on enhancing its services and addressing the challenges faced in its operational landscape. In the broader market context, the stock is affordable at $0.20 making it suitable for budget-conscious investors. However, it has a low average trading volume of 1,115,505.00 indicating lower market activity, which may affect liquidity. With a market capitalization of $8,989,164.00 the company is classified as a small-cap player, which often involves a different risk and growth potential compared to larger firms. It is a key player in the Medical - Devices industry, contributing significantly to the overall market landscape while pushing the boundaries of technology. Additionally, it belongs to the Healthcare sector, driving innovation and growth, as it seeks to improve the health and performance of its clients amid the evolving demands of the industry.

What is DIH Holdings US, Inc. Class A Common Stock (DHAI)'s current stock price?

The current stock price of DIH Holdings US, Inc. Class A Common Stock (DHAI) is $0.20 as of 2025-05-14. Prices may fluctuate during the trading day. For real-time updates, check your brokerage platform or financial news websites.

Investing in DIH Holdings US, Inc. Class A Common Stock (DHAI) depends on multiple factors, including revenue growth, profit margins, debt-to-equity ratio, earnings per share, and return on equity. Analysts have rated it as B-, with a Bullish outlook. Always conduct your own research before investing.

Analysts predict DIH Holdings US, Inc. Class A Common Stock stock to fluctuate between $0.12 (low) and $3.67 (high) in the next 365 days, reflecting market expectations and potential volatility.

As of 2025-05-14, DIH Holdings US, Inc. Class A Common Stock's market cap is $8,989,164, based on 47,336,304 outstanding shares.

Compared to Meta Platforms, Inc. Class A Common Stock, DIH Holdings US, Inc. Class A Common Stock has a Lower Market-Cap, indicating a difference in performance.

To buy DIH Holdings US, Inc. Class A Common Stock (DHAI) stock: Open a brokerage account (e.g., Robinhood, TD Ameritrade, E-Trade). Search for DHAI. Place an order (Market, Limit, etc.).

The best time to invest depends on market trends and technical indicators, which show a Bullish trend based on economic conditions and company performance.

Revenue: $64,473,000 | EPS: -$0.32 | Growth: 52.38%.

Visit https://www.dih.com/investor-relations for detailed financial reports.

You can explore historical data from here

All-time high: $3.67 (2024-07-10) | All-time low: $0.12 (2025-04-10).

Key trends include market demand, economic conditions, interest rates, and industry competition, which influence the stock's performance.


News

DHAI

globenewswire.com

DIH Announces Closing of $4.6 Million Public Offering

NORWELL, Mass., Feb. 03, 2025 (GLOBE NEWSWIRE) -- DIH Holding US, Inc. ("DIH" or the “Company”) (NASDAQ: DHAI), a global provider of advanced robotic devices used in rehabilitation, which incorporate visual stimulation in an interactive manner to enable clinical research and intensive functional rehabilitation and training in patients with walking impairments, reduced balance and/or impaired arm and hand functions, today announced the closing of its previously announced public offering of an aggregate of 5,937,100 units at a public offering price of $0.7832 per unit. Each unit consists of one share of Class A common stock and one Class A warrant to purchase one share of Class A common stock. The Class A warrants will have an exercise price of $0.7832 per share, are exercisable immediately upon issuance, and will expire on the five-year anniversary of the original issuance date. The shares of Class A common stock and the Class A warrants comprising the units are immediately separable and were issued separately in this offering.

DHAI

globenewswire.com

DIH Announces Pricing of $4.6 Million Public Offering

NORWELL, Mass., Jan. 31, 2025 (GLOBE NEWSWIRE) -- DIH Holding US, Inc. ("DIH" or the “Company”) (NASDAQ: DHAI), a global provider of advanced robotic devices used in rehabilitation, which incorporate visual stimulation in an interactive manner to enable clinical research and intensive functional rehabilitation and training in patients with walking impairments, reduced balance and/or impaired arm and hand functions, today announced the pricing of its public offering of an aggregate of 5,937,100 units at a public offering price of $0.7832 per unit. Each unit consists of one share of Class A common stock (or pre-funded warrant in lieu thereof) and one Class A warrant to purchase one share of Class A common stock. The Class A warrants will have an exercise price of $0.7832 per share, will be exercisable immediately upon issuance, and will expire on the five-year anniversary of the original issuance date. The shares of Class A common stock (or pre-funded warrants) and the Class A warrants comprising the units are immediately separable and will be issued separately in this offering. The closing of the offering is expected to occur on or about February 3, 2025, subject to the satisfaction of customary closing conditions.

DHAI

globenewswire.com

DIH Announces Strategic Partnership with Nobis Rehabilitation Partners

NORWELL, Mass. and ALLEN, Texas, Jan. 28, 2025 (GLOBE NEWSWIRE) -- DIH Holding US, Inc. ("DIH")(NASDAQ:DHAI), a global provider of advanced robotic devices used in rehabilitation, which incorporate visual stimulation in an interactive manner to enable clinical research and intensive functional rehabilitation and training in patients with walking impairments, reduced balance and/or impaired arm and hand functions, today announced its new partnership with Nobis Rehabilitation Partners. This collaboration signifies an important advancement as Nobis plans to integrate Andago®, an overground gait and balance training device, into every one of their newly established hospitals.

DHAI

globenewswire.com

DIH Appoints Shepherd Center as a DIH Center of Excellence

NORWELL, Mass. and ATLANTA, Dec. 23, 2024 (GLOBE NEWSWIRE) -- DIH Holding US, Inc. ("DIH")(NASDAQ:DHAI), a global provider of advanced robotic devices used in rehabilitation, which incorporate visual stimulation in an interactive manner to enable clinical research and intensive functional rehabilitation and training in patients with walking impairments, reduced balance and/or impaired arm and hand functions, today announced the appointment of Shepherd Center as DIH Center of Excellence. Through this partnership, DIH and Shepherd Center aim to further enhance rehabilitation outcomes and drive advancements in rehabilitation, creating new opportunities for patient recovery.

DHAI

globenewswire.com

DIH Appoints Sheltering Arms Institute as a DIH Center of Excellence

NORWELL, Mass. and RICHMOND, Va., Dec. 16, 2024 (GLOBE NEWSWIRE) -- DIH Holding US, Inc. ("DIH")(NASDAQ:DHAI), a global provider of advanced robotic devices used in rehabilitation, which incorporate visual stimulation in an interactive manner to enable clinical research and intensive functional rehabilitation and training in patients with walking impairments, reduced balance and/or impaired arm and hand functions, today announced the designation of Sheltering Arms Institute, a collaboration with VCU Health, as DIH Center of Excellence. By partnering with Sheltering Arms Institute, DIH continues to build a strong presence among top-tier healthcare providers dedicated to enhancing patient recovery journeys through innovation-driven care solutions.

DHAI

globenewswire.com

DIH Announces Second Quarter 2025 Financial Results and Restates June 30, 2024 Form 10-Q

NORWELL, Mass., Nov. 14, 2024 (GLOBE NEWSWIRE) -- DIH Holding US, Inc. ("DIH")(NASDAQ:DHAI), a global provider of advanced robotic devices used in physical rehabilitation, which incorporates visual stimulation in an interactive manner to enable clinical research and intensive functional rehabilitation and training in patients with walking impairments, reduced balance and/or impaired arm and hand functions, today announced financial results for the second fiscal quarter ended September 30, 2024, and a restatement of the financial results for the first fiscal quarter ended June 30, 2024, to account for the timing of revenue and associated cost of sales recognition for two devices sold in late June 2024.

DHAI

globenewswire.com

DIH Appoints Dietmar Dold as Chief Operating Officer

NORWELL, Mass., Nov. 04, 2024 (GLOBE NEWSWIRE) -- DIH Holding US, Inc. (“DIH”)(NASDAQ:DHAI), a leading global robotics and virtual reality (“VR”) technology provider in the rehabilitation and human performance industry, today announced the appointment of Mr. Dietmar Dold as Chief Operating Officer, effective immediately.

DHAI

globenewswire.com

DIH Announces Formation and Inaugural Meeting of Scientific Advisory Board

NORWELL, Mass., Sept. 26, 2024 (GLOBE NEWSWIRE) -- DIH Holding US, Inc. ("DIH")(NASDAQ:DHAI), a global provider of advanced robotic devices used in rehabilitation, which incorporate visual stimulation in an interactive manner to enable clinical research and intensive functional rehabilitation and training in patients with walking impairments, reduced balance and/or impaired arm and hand functions, today announced the formation of its Scientific Advisory Board (“SAB”). The newly formed SAB will advise DIH on technical and scientific pursuits, offer insights into the latest trends in the scientific and clinical communities, provide feedback on product development, and advise DIH on research plans and projects. With their expertise, DIH will continue driving its mission of improving patients' lives through advanced rehabilitation solutions.

DHAI

globenewswire.com

DIH Appoints Haapsalu Neurological Rehabilitation Center as a DIH Center of Excellence

NORWELL, Mass. and HAAPSALU, Estonia, Aug. 30, 2024 (GLOBE NEWSWIRE) -- DIH Holding US, Inc. ("DIH")(NASDAQ:DHAI), a global provider of advanced robotic devices used in physical rehabilitation, which incorporate visual stimulation in an interactive manner to enable clinical research and intensive functional rehabilitation and training in patients with walking impairments, reduced balance and/or impaired arm and hand functions, today announced that Haapsalu Neurological Rehabilitation Center (HNRC), located in Haapsalu, Estonia, has been appointed as the latest DIH Center of Excellence. Recognized for its pioneering work in neurological rehabilitation, Haapsalu Neurological Rehabilitation Center is now the first such center in the Baltics Region.

DHAI

globenewswire.com

DIH Announces Fiscal 2025 First Quarter Financial Results

NORWELL, Mass., Aug. 19, 2024 (GLOBE NEWSWIRE) -- DIH Holding US, Inc. ("DIH")(NASDAQ:DHAI), a global provider of advanced robotic devices used in physical rehabilitation, which incorporate visual stimulation in an interactive manner to enable clinical research and intensive functional rehabilitation and training in patients with walking impairments, reduced balance and/or impaired arm and hand functions, today announced financial results for the quarter ended June 30, 2024, which is the first quarter of fiscal 2025.

See all news

logo
Stocks, Indicators, Pattern screeners all at one place
Stock Screener
Forex Screener
Crypto Screener